<PAGE> 1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
[ ] FORM 10-K [ ] FORM 20-F [ ] FORM 11-K [X] FORM 10-Q [ ] FORM N-SAR
For Period Ended: March 31, 1997
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
- -------------------------------------------------------------------------------
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
- -------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
- -------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
- -------------------------------------------------------------------------------
Full Name of Registrant: Rx Medical Services Corp.
Former Name if Applicable: ARM Financial Corp.
Address of Principal Executive Office (Street and Number)
888 East Las Olas Boulevard, Suite 210
City, State and Zip Code:
Fort Lauderdale, Florida 33301
<PAGE> 2
- -------------------------------------------------------------------------------
Part II - Rules 12b-25(b) and (c)
- -------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed. (Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without reasonable effort or expense;
[ ] (b) The subject annual report semi-annual report, transition report on Form
10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
- -------------------------------------------------------------------------------
Part III - Narrative
- -------------------------------------------------------------------------------
State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof could not be filed within
the prescribed period.
The financial statements of registrant for the fiscal year ended
December 31, 1996 are presently being audited. The delay in
completing the audit is attributable to the inability of the
registrant to obtain accurate records regarding the sale of one of
the hospitals previously operated by registrant's hospital management
subsidiary. Once said audit is completed and the registrant's annual
report on Form 10-K for the fiscal year ended December 31, 1996 is
filed, registrant will be in a position to issue appropriate
unaudited financial statements for the three months ended March 31,
1997. Registrant anticipates that its Form 10-Q for the first quarter
ended March 31, 1997 will be filed on or about July 15, 1997.
- -------------------------------------------------------------------------------
Part IV - Other Information
- -------------------------------------------------------------------------------
2
<PAGE> 3
(1) Name and telephone number of person to contact in regard to this
notification
Joseph C. Wasch (954) 462-1711 [Ext. 105]
- -------------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d) of
the Securities Exchange Act of 1934 or section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report (s) been filed? If the answer is
no, identify report(s).
[ ] Yes [X] No
The annual report on Form 10-K for the fiscal year ended December 31,
1996.
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
Rx MEDICAL SERVICES CORP.
-------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: May 14, 1997 By: /s/ Randolph H. Speer
---------------------------
Randolph H. Speer
President
INSTRUCTION: The form may be signed by an executive officer of the registrant
or by any other duly authorized representative. The name and title of the
person signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority
to sign on behalf of the registrant shall be filed with the form.
- -------------------------------------------------------------------------------
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
3
